Rebekah Jordan sits down with Oliver Schacht, CEO of OpGen, to discuss the increasing prevalence of antibiotic resistance in Urinary Tract Infections (UTIs), and how OpGen’s Unyvero can quicken the AR diagnosis process.
Jason Smith, CTO, AI & Analytics, Within3, describes the possibilities made by AI in supporting the life sciences sector, and how it can allow pharma experts to produce real time results and yield better insights.
Ben Appleton and Mohammed Khimji from patent and trade mark firm, Wilson Gunn, explore the complexities, as well as the possibilities, of obtaining patent protection in Europe for inventions relating to biomarkers.
Matt Hale, international sales & marketing director, HRS Heat Exchangers, explains the importance of evaporation in maintaining the characteristics of CBD oil as opposed to traditional extraction processes.
Decision makers from European pharma and biotech companies will hear from two speakers at Connect in Pharma, Jean-François Hilaire (Recipharm) and Christian Wölbeling (Körber Pharma Software), on how to ensure a strong future in European pharma.
Himanshu Nivsarkar, senior manager marketing New Product Introduction, 3M Separation and Purification Sciences Division, explains the benefits and challenges of both single-use and stainless-steel bioreactors, and which is best for your facility.
David O’Connell, director of Scientific Affairs at PCI Pharma Services, Tredegar site, shares insight on how CDMOs, like PCI, can provide end-to-end solutions in the growing demand of high potency manufacturing.
Mahesh Veerina, president and CEO - ParkourSC, describe solutions that could bring improved levels of digitisation, visibility and control to pharmaceutical supply chain environments.
Christopher Brau, R&D process development manager - Thermo Fisher Scientific, explains how continuous perfusion can support small molecule manufacturers and achieve fully intensified biomanufacturing.
Natasha Rivas, vice president of quality and regulatory, and Jose Cruz, director of vector manufacturing at Genezen, explore the difficulties in ensuring cGMP compliance is achieved throughout viral vector production.
A new report sets out 20 key recommendations which, upon implementation, would set the UK on a path to become the global leader in cannabinoid innovation.
